News Release

Pharmacy assessment of penicillin allergies finds safe, less-expensive options

Improved allergy documentation allows patient choices that save hospital $21,500 in three months

Peer-Reviewed Publication

ASHP (American Society of Health-System Pharmacists)

LAS VEGAS (Dec. 9, 2019) -- A pharmacy-driven assessment found more than half of patients with reported penicillin allergies were able to take antibiotics from the same drug class rather than resorting to substitutes that may be more costly, have more side effects and have other downsides, according to research presented at the ASHP (American Society of Health-System Pharmacists) 54th Midyear Clinical Meeting and Exhibition. The substitution saved one hospital nearly $21,500 by switching 43 patients in just three months.

Penicillin allergies, reported by up to 10 percent of the population, are the most common drug allergy, but researchers believe that true penicillin allergies are actually rarer, with an overall estimated frequency of less than 1 percent.

"The prevalence of this perceived allergy makes our study particularly useful to hospitals and healthcare systems as they look at better patient care and cost reductions. Working together, pharmacists and other medical professionals can find alternatives that work for some patients. A multi-disciplinary approach is key to optimizing therapy in patients with a reported penicillin allergy," said Rita Chamoun, Pharm.D., Clinical Staff Pharmacist at Baptist Hospital of Miami and lead author of the study.

For the study, Baptist Hospital pharmacists interviewed patients with reported allergies and then carefully reviewed their medication history prior to verifying orders for substitute antibiotics. Penicillin is among a variety of antibiotics in a class known as beta-lactams, and patients who report allergies to penicillin are often treated with broad-spectrum non-beta-lactam alternatives. These alternatives are often more expensive and associated with more side effects, factors that potentially limit the advantages of antimicrobial stewardship.

In reviewing patient histories during a three-month span, researchers found that 68 percent, or 43 out of 63 patients, with reported penicillin allergies had previously successfully used other beta-lactams, most often cephalosporins. Pharmacists recommended switching to a beta-lactam antibiotic with 100 percent prescriber acceptance. Aztreonam and levofloxacin were the most commonly prescribed non-beta-lactam antibiotics prior to the allergy assessment. Clinicians prefer to save these broad-spectrum antibiotics for situations where standard treatments are not effective to ensure the bacteria do not become resistant to this next line of defense.

"By improving penicillin allergy documentation and encouraging both pharmacists and prescribers to thoroughly evaluate allergies and prior cephalosporin use, the use of non-beta-lactam alternatives can be reduced significantly," Chamoun said.

Authors noted that the study does not suggest that every patient with a penicillin allergy can take cephalosporins, but instead concluded that it is important to thoroughly evaluate allergy documentation and prior beta-lactam use.

"While our study focused on the use of a pharmacy-driven allergy assessment to reduce non-beta-lactam antibiotic use, we also aimed to improve allergy documentation," Chamoun said. "We found that improving allergy documentation goes hand-in-hand with optimizing selection of antibiotic therapy."


The research entitled Improving penicillin allergy documentation and its effect on antibiotic prescribing at a community hospital will be presented at the ASHP 54th Midyear Clinical Meeting and Exhibition on Monday, Dec. 9, from 2 p.m. to 3:30 pm PST.

The research study team out of Baptist Hospital of Miami included Rita Chamoun, Pharm.D.; Olga Bendyk, Pharm.D., BCPS; Residency Program Director Radhan Gopalani, Pharm.D., BCPS; Amy Montes, Pharm.D., BCPS, and Thomas Wolfel, Pharm.D., BCCCP.

About the ASHP Midyear Clinical Meeting & Exposition

ASHP's Midyear Clinical Meeting and Exhibition is the largest gathering of pharmacy professionals in the world. Attended by more than 25,000 pharmacy professionals from across the globe, the Midyear meeting provides opportunities for professional development, networking, enhancing practice skills, and staying current with the latest products and innovations. Tag and follow ASHP and the meeting on social media, #ASHP19 and @ASHPOfficial.

About ASHP

ASHP represents pharmacists who serve as patient care providers in acute and ambulatory settings. The organization's 50,000 members include pharmacists, student pharmacists, and pharmacy technicians. For more than 75 years, ASHP has been at the forefront of efforts to improve medication use and enhance patient safety. For more information about the wide array of ASHP activities and the many ways in which pharmacists advance healthcare, visit ASHP's website,, or its consumer website,

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.